John Digman
jdigman.bsky.social
John Digman
@jdigman.bsky.social
Clinical Pharmacist working in Primary Care, Husband, Father, Disciple of Jesus Christ. Interested in Clinical Pharmacy, General Practice, Politics, Christianity.
Yes I've had that thought before too. If no pre-ICS FBC, but eosinophils normal on ICS/LABA, pt stable and no other Hx of inflam resp disease then probably reasonable to try switch. Can always recheck FBC again at later date to check eosinophil trend 👍.
November 17, 2024 at 2:53 PM
Not a resp expert...

But my understanding is if eosinophils normal + no PMH asthma, then ideally to remove ICS as can inc risk of pneumonia in COPD pts. So yes - switch to LABA/LAMA.

Totally agree - hard to get patients on board when they feel strongly about their existing txt!
November 17, 2024 at 8:11 AM
Useful paper. Fesoterodine's DT price hugely reduced in recent months, so no excuse to prescribe oxybutynin any more based on cost. Fesoterodine now included as 1st line on Somerset Prescribing Formulary
November 15, 2024 at 10:20 PM